Corresponding to our study, high expression of SLC2A1 has been found to be associated with inferior outcomes in various malignancies in adults, including pancreatic cancer, colorectal cancer, breast cancer, lung cancer, and others [27,28,29,30]. Here, SLC2A1 is linked to breast carcinoma.